efavirenz-based antiretroviral therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for efavirenz-based antiretroviral therapy, covering 2021-11-30 to 2021-11-30. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy [Phase 2]